Novartis CEO Vas Narasimhan Talks Psoriasis Drug, China Growth, M&A
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Novartis CEO Vas Narasimhan Talks Psoriasis Drug, China Growth, M&A
-
Narrated by:
-
By:
About this listen
Novartis announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise. Novartis CEO Vasant Narasimham speaks with Bloomberg's Scarlet Fu on the impact of pharma tariffs.
See omnystudio.com/listener for privacy information.
What listeners say about Novartis CEO Vas Narasimhan Talks Psoriasis Drug, China Growth, M&A
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.